PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
27-Aug-2024 ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
27-Aug-2024 Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 Published in JITC Transgene
27-Aug-2024 New drug trial offers hope to 200,000 people with ‘hidden’ lung condition EMBARC
23-Aug-2024 Cherwell to spotlight Delivering Knowledge initiative at PHSS Annual Conference 2024 Cherwell
23-Aug-2024 Asthma + Lung UK and Sanofi join forces to empower healthcare professionals to improve health outcomes for people with COPD Asthma + Lung UK  
22-Aug-2024 DATA SUPPORTING FDA APPROVAL PUBLISHED IN HIGH-IMPACT JOURNAL ANGLE plc
22-Aug-2024 PureTech Appoints Michele Holcomb, PhD, to Board of Directors PureTech Health plc
22-Aug-2024 Unaudited Interim Results for the six months ended 30 June 2024 Cambridge Cognition Holdings plc
22-Aug-2024 Arrival of deadlier ‘clade I’ mpox in Europe highlights need for better testing and treatment: expert London Medical Laboratory
22-Aug-2024 Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Touchlight
22-Aug-2024 GermFree and Caring Cross partner to transform access to cellular gene therapies GermFree
22-Aug-2024 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development Vandria SA
22-Aug-2024 Kelso Pharma appoints first Director of Corporate Development as international expansion continues Kelso Pharma
22-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
22-Aug-2024 London BioScience Innovation Centre welcomes Baseimmune Ltd to its new fully fitted grow-on lab space within the Apex Building London BioScience Innovation Centre
22-Aug-2024 RedHill Announces Positive Obesity and Diabetes Results with Opaganib RedHill Biopharma
22-Aug-2024 Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project Cumulus Oncology
22-Aug-2024 Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor Adcendo ApS and Multitude Therapeutics Inc
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 osteolabs Publishes First Real-World Evidence Data from Close to 3,000 OsteoTest Patient Samples osteolabs